The SAFEST way: The right medicine to the right patient at the right time

According to the World Health Organisation (WHO)1, the leading causes of injury and avoidable harm in healthcare systems across the world are unsafe medication practices and medication errors. To address these obstacles and ensure more precise prescriptions and improved quality in the preparation and management of medicinal products in Norway, we have contributed to delivering a new digital solution that hospitals and pharmacies can use to enhance patients’ safety and trust in medicines.

Medicines are essential. They contribute to patients’ medical and mental well-being and help keep society healthy and safe. But with so many types of medication, and so many dosages and methods of administering them, it can be challenging to keep track of prescribing, transcribing, dispensing, monitoring, etc. Errors can occur at several different stages of medication processes, hereunder weak administration practices1. This can lead to a lack of patient trust – and is a risk to their safety.

“Medicines are essential to protecting society from diseases. The new SAFEST solution helps hospitals and pharmacies make better-informed choices about the medicines available and the best ways to prescribe them."

As a strategic partner for the Norwegian Medicines Agency (NOMA), we are helping to develop and deliver a new digital solution called SAFEST. This closed-loop medication administration system solution gives medical professionals up-to-date medicine information, including nutrition, dosage formats and strength, and inventory management. SAFEST will, in addition, deliver improved quality in the preparation and management of medicinal products; reduce the maintenance cost of regional medicinal product registers; enable a regional and national exchange of standardised medicinal product data, and support the prescription of medications based on active substance rather than brand.

Although SAFEST is in its early stages, the solution is already making a difference to patients and has been recognised by the European Commission’s innovation radar, with NOMA awarded the title of ‘key innovator’ for the work.

  1. World Health Organization: Medication Without Harm